Jan Münch
Has grant
Research Interests
Explore related searches
Contact this professor
Recent Grants
Grant: Close
Targeting CXCR4 to suppress virus-induced activation of plasmacytoid dendritic cells
Open Date: 2018-01-01
Close Date:
Grant: Close
Crossing Barriers with bio-based Therapeutics
Open Date: 2017-01-01
Close Date: 2018-12-31
Grant: Close
Mechanism and structural basis of peptide fibrils affecting viral infection (A03)
Open Date: 2017-01-01
Close Date:
Grant: Close
Characterization and optimization of the CXCR4 antagonist EPI- (A06)
Open Date: 2017-01-01
Close Date:
Grant: Close
Identification and characterization of antimicrobial peptides from major pathogen entry and replication sites (A02)
Open Date: 2017-01-01
Close Date:
Articles (11)
Semen enhances transmitted/founder HIV-1 infection and only marginally reduces antiviral activity of broadly neutralizing antibodies
Topically applied microbicides may play a critical role in preventing sexual transmission of human immunodeficiency virus type 1 (HIV-1); however, their efficacy can be compromised by amyloid fibrils present in semen, which significantly increase HIV-1 infectivity. This phenomenon may have contributed to the failure of most microbicide candidates in clinical settings. Understanding the impact of semen on microbicide effectiveness is thus crucial. In our study, we evaluated the influence of semen on the neutralizing activity of broadly neutralizing antibodies (bNAbs), including PG16, PGT121, 10–1074, 3BNC117, and VRC01, which are potential microbicide candidates. We found that semen enhances infection of HIV-1 transmitted/founder viruses but only marginally affects the neutralizing activity of tested antibodies, suggesting their potential for microbicide application. Our findings underscore the need to consider semen-mediated enhancement when evaluating and developing microbicides and highlight the potential of incorporating HIV-1 bNAbs in formulations to enhance efficacy and mitigate HIV-1 transmission during sexual encounters. IMPORTANCE This study examined the impact of semen on the development of microbicides, substances used to prevent the transmission of HIV-1 during sexual activity. Semen contains certain components that can render the virus more infectious, posing a challenge to microbicide effectiveness. Researchers specifically investigated the effect of semen on a group of powerful antibodies called broadly neutralizing antibodies, which can neutralize a large spectrum of different HIV-1 variants. The results revealed that semen only had a minimal effect on the antibodies' ability to neutralize the virus. This is promising because it suggests that these antibodies could still be effective in microbicides, even in the presence of semen. Understanding this interaction is crucial for developing better strategies to prevent HIV-1 transmission. By incorporating the knowledge gained from this study, scientists can now focus on creating microbicides that consider the impact of semen, bringing us closer to more effective prevention methods.
Year:
2024
Collaborators (8)
Barbara Spellerberg
-
Guillermin Agüero-Chapin
University of Porto
Agostinho Antunes
Professor
University of Porto
Ion Cristian Cirstea
Ulm University
Tristan Bereau
Prof. at Heidelberg University
Heidelberg University
Melpomeni Fani
University Hospital Basel
Konstantin MJ Sparrer
Ulm University
Frank Rosenau
Ulm University

How do I reach out?
Sign in for free to see their profile details and contact information.